Phase IV Study of Afatinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer

被引：0

作者：

Thongprasert, Sumitra ^{[1
]}

Boldeanu, Cosmin ^{[2
]}

Radosavljevic, Davorin ^{[3
]}

Petrovic, Marina ^{[4
]}

Jones, Hilary ^{[5
]}

Cseh, Agnieszka ^{[6
]}

Gaafar, Rabab ^{[7
]}

机构：

[1] Chiang Mai Univ, Fac Med, Dept Med, Chiang Mai 50000, Thailand

[2] Braila Cty Emergency Hosp, Braila, Romania

[3] Inst Oncol & Radiol Serbia, Belgrade, Serbia

[4] Clin Ctr Kragujevac, Kragujevac, Serbia

[5] Boehringer Ingelheim Ltd, Dept Oncol, Bracknell, Berks, England

[6] Boehringer Ingelheim Rcv Gmbh & Co Kg, Dept Oncol, Vienna, Austria

[7] Cairo Univ, Natl Canc Inst, Cairo, Egypt

来源：

JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期

关键词：

afatinib; NSCLC; EGFR mutated; Second-line;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P3.01-088

引用

页码：S667 / S667

页数：1

共 50 条

[31] Locally Advanced, Unresectable Non-Small Cell Lung Cancer
Puri, Sonam
Saltos, Andreas
Perez, Bradford
Le, Xiuning
Gray, Jhanelle E.
CURRENT ONCOLOGY REPORTS, 2020, 22 (04)
[32] Locally advanced non-small cell lung cancer.
Cohen E.E.
Vokes E.E.
Current Treatment Options in Oncology, 2001, 2 (1) : 27 - 42
[33] Management of locally advanced non-small cell lung cancer
Perng, RP
LUNG CANCER, 2003, 42 : S1 - S1
[34] Stage IV non-small cell lung cancer.: Duration of chemotherapy for locally advanced non small cell lung cancers
Vergnenegre, A.
REVUE DES MALADIES RESPIRATOIRES, 2006, 23 (05) : S72 - S77
[35] Afatinib in EGFR mutation positive advanced non-small cell lung cancer
Davies, R. S.
Brewster, A. E.
Button, M. R.
Lester, J. F.
LUNG CANCER, 2016, 91 : S22 - S22
[36] Palliative thoracic radiotherapy in locally advanced/metastatic non-small cell lung cancer (NSCLC)
Maclennan, K.
Campbell, S.
Little, F.
Erridge, S.
Evans, T.
Price, A.
LUNG CANCER, 2016, 91 : S53 - S54
[37] Advances in Treatment of Locally Advanced or Metastatic Non-Small Cell Lung Cancer: Targeted Therapy
Giustini, Nicholas P.
Jeong, Ah-Reum
Buturla, James
Bazhenova, Lyudmila
CLINICS IN CHEST MEDICINE, 2020, 41 (02) : 223 - +
[38] Tislelizumab as monotherapy or in combination with chemotherapy in locally advanced or metastatic non-small cell lung cancer
Olivier, Alexandre
Basse, Clemence
BULLETIN DU CANCER, 2025, 112 (01)
[39] State-of-the art treatment of locally advanced and metastatic non-small cell lung cancer
Bunn, PA
ANTI-CANCER DRUGS, 2001, 12 : S3 - S8
[40] Phase Ib trial of afatinib and BI 836845 in advanced non-small cell lung cancer (NSCLC)
Tan, D.
Lin, C. -C.
Huang, D. Chin-Lun
Jung, H.
Bogenrieder, T.
Park, K.
ANNALS OF ONCOLOGY, 2015, 26 : 147 - 147

← 1 2 3 4 5 →